Adjuvant therapy (AT) with raltitrexed (RAL) in colorectal cancer (CRC) patients (pts) intolerant of 5-fluorouracil (5FU).

被引：0
|
作者：
Wilson, K. S.
Barnett, J. B.
Gill, S.
Khoo, K. E.
Fitzgerald, C. A.
机构：
[1] British Columbia Canc Agcy, Victoria, BC, Canada
[2] British Columbia Canc Agcy, Kelowna, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3571
引用
收藏
页码：163S / 163S
页数：1
相关论文
共 50 条
  • [41] UFT. Biochemical modulation for 5-fluorouracil (5FU)
    Taguchi, T
    BALKAN CONGRESS OF ONCOLOGY, 1996, : 47 - 50
  • [42] On 5-fluorouracil therapy of colorectal cancer
    Jensen, Soren Astrup
    DANISH MEDICAL JOURNAL, 2013, 60 (07):
  • [43] Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity
    C-H Köhne
    P Thuss-Patience
    M Friedrich
    PT Daniel
    A Kretzschmar
    T Benter
    B Bauer
    R Dietz
    B Dörken
    British Journal of Cancer, 1998, 77 : 973 - 977
  • [44] A phase I dose escalation of hydroxyurea (HU) in addition to continuous infusion 5-fluorouracil (5FU) in patients with advanced colorectal cancer
    Last, K
    Lofts, FJ
    Thompson, F
    Mansi, JL
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S14 - S14
  • [45] A phase II study with 5-fluorouracil (5FU), leucovorin (LV) and irinotecan (CPT-11) in patients with metastatic colorectal cancer
    Destefanis, M
    Dalla Mola, A
    Ostellino, O
    Capello, C
    Milanesi, E
    Grillo, C
    Castiglione, F
    Venturino, A
    Porcile, G
    ANNALS OF ONCOLOGY, 2000, 11 : 67 - 67
  • [46] Raltitrexed (Tomudex):: an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity
    Köhne, CH
    Thuss-Patience, P
    Friedrich, M
    Daniel, PT
    Kretzschmar, A
    Benter, T
    Bauer, B
    Dietz, R
    Dörken, B
    BRITISH JOURNAL OF CANCER, 1998, 77 (06) : 973 - 977
  • [47] Phase II study of oxaliplatin (OHP) and protracted 5-fluorouracil (5FU) infusion in pretreated metastatic colorectal cancer (MCRC) patients
    Mini, E
    Pinto, C
    Angelelli, B
    Dentico, P
    Piana, E
    Nobili, S
    Gentile, AL
    Scicolone, S
    Mazzei, T
    Martoni, A
    ANNALS OF ONCOLOGY, 2000, 11 : 73 - 73
  • [48] SENSITIVE HPLC ASSAY FOR 5-FLUOROURACIL (5FU) - COMPARISON WITH GLC
    CHRISTOPHIDIS, N
    MIHALY, G
    VAJDA, F
    LOUIS, W
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1979, 6 (06) : 679 - 680
  • [49] A simplified bi-monthly regimen with leucovorin (LV) and 5-Fluorouracil (5FU) for metastatic colorectal cancer (MCRC)
    Tournigand, C
    de Gramont, A
    Louvet, C
    Andre, T
    Carola, E
    Gilles-Amar, V
    Maindrault-Goebel, F
    Lotz, JP
    Molitor, JL
    ANNALS OF ONCOLOGY, 1998, 9 : 40 - 40
  • [50] Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin
    Pronzato, P
    Vaira, F
    Vigani, A
    Losardo, P
    Bertelli, G
    ANTICANCER RESEARCH, 1995, 15 (6B) : 2679 - 2682
12345